153 related articles for article (PubMed ID: 17053842)
1. Adhesion molecule profiles of B-cell non-Hodgkin's lymphomas in the leukemic phase.
Matos DM; Rizzatti EG; Garcia AB; Gallo DA; Falcão RP
Braz J Med Biol Res; 2006 Oct; 39(10):1349-55. PubMed ID: 17053842
[TBL] [Abstract][Full Text] [Related]
2. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
[TBL] [Abstract][Full Text] [Related]
3. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecules in B-chronic lymphoproliferative disorders.
Angelopoulou MK; Kontopidou FN; Pangalis GA
Semin Hematol; 1999 Apr; 36(2):178-97. PubMed ID: 10319387
[TBL] [Abstract][Full Text] [Related]
5. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias.
Csanaky G; Matutes E; Vass JA; Morilla R; Catovsky D
Leukemia; 1997 Mar; 11(3):408-15. PubMed ID: 9067581
[TBL] [Abstract][Full Text] [Related]
6. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia.
Finn WG; Singleton TP; Schnitzer B; Ross CW; Stoolman LM
Hum Pathol; 2001 Jan; 32(1):66-73. PubMed ID: 11172297
[TBL] [Abstract][Full Text] [Related]
7. Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin's lymphoma.
Jacob MC; Agrawal S; Chaperot L; Giroux C; Gressin R; Le Marc'Hadour F; Favre M; Sotto JJ; Bensa JC; Plumas J
Leukemia; 1999 Sep; 13(9):1428-33. PubMed ID: 10482995
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 expression in B-cell lymphomas.
Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
10. Expression of adhesion molecules in childhood B-lineage-cell neoplasms.
Hara J; Matsuda Y; Fujisaki H; Tokimasa S; Ohta H; Osagi Y; Takai K
Int J Hematol; 2000 Jul; 72(1):69-73. PubMed ID: 10979212
[TBL] [Abstract][Full Text] [Related]
11. Adhesion molecules expression in CLL: Potential impact on clinical and hematological parameters.
Kamel AM; El-Sharkawy NM; Osman RA; Abd El-Fattah EK; El-Noshokaty E; Abd El-Hamid T; Kandeel EZ
J Egypt Natl Canc Inst; 2016 Mar; 28(1):31-7. PubMed ID: 26873628
[TBL] [Abstract][Full Text] [Related]
12. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
[TBL] [Abstract][Full Text] [Related]
13. Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.
Martinez A; Pittaluga S; Rudelius M; Davies-Hill T; Sebasigari D; Fountaine TJ; Hewitt S; Jaffe ES; Raffeld M
Am J Surg Pathol; 2008 Aug; 32(8):1190-200. PubMed ID: 18580679
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
[TBL] [Abstract][Full Text] [Related]
15. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
[TBL] [Abstract][Full Text] [Related]
16. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of cell adhesion molecules in B-zone small lymphocytic lymphoma and other well-differentiated lymphocytic disorders.
Pinto A; Carbone A; Gloghini A; Marotta G; Volpe R; Zagonel V
Cancer; 1993 Aug; 72(3):894-904. PubMed ID: 8334643
[TBL] [Abstract][Full Text] [Related]
18. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis.
Thieblemont C; Chettab K; Felman P; Callet-Bauchu E; Traverse-Glehen A; Berger F; Dumontet C; Cerutti C; Baseggio L; Salles G; Paultre C; Coiffier B; McGregor JL
Leukemia; 2002 Nov; 16(11):2326-9. PubMed ID: 12399979
[No Abstract] [Full Text] [Related]
20. Expression of adhesion molecules on leukemic B cells from chronic lymphocytic leukemia patients with predominantly splenic manifestations.
Bairey O; Zimra Y; Rabizadeh E; Shaklai M
Isr Med Assoc J; 2004 Mar; 6(3):147-51. PubMed ID: 15055269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
